Healthcare -
Biotechnology - NYSE - CH
$ 1.83
4.57 %
$ 177 M
Market Cap
-0.77
P/E
ADCT - COST OF REVENUE
Cost of Revenue ADCT - ADC Therapeutics SA
2.53 M
LAST VALUE
34.74%
2 YEAR CAGR
-53.64%
5 YEAR CAGR
0.00%
10 YEAR CAGR